236 related articles for article (PubMed ID: 10440415)
1. Single-dose pharmacodynamics of clopidogrel.
Thebault JJ; Kieffer G; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():3-8. PubMed ID: 10440415
[TBL] [Abstract][Full Text] [Related]
2. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects.
Thebault JJ; Kieffer G; Lowe GD; Nimmo WS; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():9-14. PubMed ID: 10440416
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects.
Savcic M; Hauert J; Bachmann F; Wyld PJ; Geudelin B; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():15-9. PubMed ID: 10440417
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel does not affect the pharmacokinetics of theophylline.
Caplain H; Thebault JJ; Necciari J
Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
[TBL] [Abstract][Full Text] [Related]
5. Long-term activity of clopidogrel: a three-month appraisal in healthy volunteers.
Caplain H; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():21-4. PubMed ID: 10440418
[TBL] [Abstract][Full Text] [Related]
6. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
[TBL] [Abstract][Full Text] [Related]
7. Prolonged heparin administration during clopidogrel treatment in healthy subjects.
Caplain H; D'Honneur G; Cariou R
Semin Thromb Hemost; 1999; 25 Suppl 2():61-4. PubMed ID: 10440426
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
[TBL] [Abstract][Full Text] [Related]
11. Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease.
Lev EI; Arikan ME; Vaduganathan M; Alviar CL; Tellez A; Mathuria N; Builes A; Granada JF; del Conde I; Kleiman NS
Am Heart J; 2007 Oct; 154(4):694.e1-7. PubMed ID: 17892993
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin.
Husted S; Emanuelsson H; Heptinstall S; Sandset PM; Wickens M; Peters G
Eur Heart J; 2006 May; 27(9):1038-47. PubMed ID: 16476694
[TBL] [Abstract][Full Text] [Related]
13. Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
Cuisset T; Frere C; Quilici J; Uhry S; Morange PE; Mouret JP; Gaborit B; Bali L; Moro PJ; Lambert M; Bonnet JL
Thromb Res; 2009 May; 124(1):33-6. PubMed ID: 18990434
[TBL] [Abstract][Full Text] [Related]
14. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E;
Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of 14C-labeled clopidogrel.
Lins R; Broekhuysen J; Necciari J; Deroubaix X
Semin Thromb Hemost; 1999; 25 Suppl 2():29-33. PubMed ID: 10440420
[TBL] [Abstract][Full Text] [Related]
16. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
Small DS; Farid NA; Li YG; Ernest CS; Payne CD; Salazar DE; Winters KJ
Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
[TBL] [Abstract][Full Text] [Related]
17. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation.
Brandt JT; Payne CD; Wiviott SD; Weerakkody G; Farid NA; Small DS; Jakubowski JA; Naganuma H; Winters KJ
Am Heart J; 2007 Jan; 153(1):66.e9-16. PubMed ID: 17174640
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial.
Tang YD; Rinder HM; Katz SD
Am Heart J; 2007 Sep; 154(3):494.e1-7. PubMed ID: 17719296
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
Jakubowski JA; Payne CD; Li YG; Farid NA; Brandt JT; Small DS; Salazar DE; Winters KJ
Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
